A Mouse Model for Juvenile Doxorubicin-Induced Cardiac Dysfunction

This publication has 47 references indexed in Scilit:

• Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy
  American Journal of Physiology-Heart and Circulatory Physiology, 2008
• Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy
  Laboratory Investigation, 2007
• Overexpression of Bone Morphogenetic Protein 10 in Myocardium Disrupts Cardiac Postnatal Hypertrophic Growth
  Journal of Biological Chemistry, 2006
• Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin
  Circulation, 2006
• A novel transgenic mouse model reveals deregulation of the ubiquitin‐proteasome system in the heart by doxorubicin
  The FASEB Journal, 2005
• Phosphorylation-Dependent Degradation of p300 by Doxorubicin-Activated p38 Mitogen-Activated Protein Kinase in Cardiac Cells
  Molecular and Cellular Biology, 2005
• Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure
  Circulation, 2004
• Subcellular effects of adriamycin in the heart: A concise review
  Journal of Molecular and Cellular Cardiology, 1987
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  Proceedings of the National Academy of Sciences, 1979
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970